123 related articles for article (PubMed ID: 26392387)
21. Primary Cutaneous Extranodal Natural Killer/T-Cell Lymphoma Misdiagnosed as Peripheral T-Cell Lymphoma: The Importance of Consultation/Referral and Inclusion of EBV In Situ Hybridization for Diagnosis.
Win KT; Liau JY; Chen BJ; Takata K; Chen CY; Li CC; Hsiao CH; Chuang SS
Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):105-11. PubMed ID: 25710587
[TBL] [Abstract][Full Text] [Related]
22. [Current approaches to diagnosing and treating primary cutaneous lymphomas on the basis of a new WHO-EORTC classification, cutaneous T-cell lymphomas].
Belousova IE; Kazakov DV; Krivolapov IuA
Arkh Patol; 2007; 69(5):11-7. PubMed ID: 18074813
[TBL] [Abstract][Full Text] [Related]
23. Health-related Quality of Life in Cutaneous Lymphomas: Past, Present and Future.
Jonak C; Porkert S; Oerlemans S; Papadavid E; Molloy K; Lehner-Baumgartner E; Cozzio A; Efficace F; Scarisbrick J
Acta Derm Venereol; 2019 Jun; 99(7):640-646. PubMed ID: 30868169
[TBL] [Abstract][Full Text] [Related]
24. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
[TBL] [Abstract][Full Text] [Related]
25. [Current therapy concepts in cutaneous T-cell lymphomas].
Nestle FO; Häffner AC; Schmid MH; Dummer R; Burg G
Schweiz Med Wochenschr; 1997 Feb; 127(8):311-20. PubMed ID: 9157537
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous lymphomas and COVID-19: What is known so far?
Elmasry MF; Youssef R; Elbendary A; Helmy K; Abdelkader HA
Dermatol Ther; 2021 Jan; 34(1):e14463. PubMed ID: 33112053
[TBL] [Abstract][Full Text] [Related]
27. Illness perception in Chinese adults with epilepsy.
Ji H; Zhang L; Li L; Gong G; Cao Z; Zhang J; Zhou N; Wang Y; Tu H; Wang K
Epilepsy Res; 2016 Dec; 128():94-101. PubMed ID: 27833067
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
[TBL] [Abstract][Full Text] [Related]
29. Somatostatin receptor scintigraphy in primary cutaneous T- and B-cell lymphomas.
Valencak J; Trautinger F; Raderer M; Chott A; Der-Petrossian M; Ivancic-Brandenberger E; Knobler R; Kurtaran A; Hoffmann M
J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):13-7. PubMed ID: 19515078
[TBL] [Abstract][Full Text] [Related]
30. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
Vidulich KA; Talpur R; Bassett RL; Duvic M
Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
[TBL] [Abstract][Full Text] [Related]
31. Cognition/Psychological Burden and Resilience in Cutaneous T-Cell Lymphoma and Psoriasis Patients: Real-Life Data and Implications for the Treatment.
Damiani G; Tacastacas JD; Wuerz T; Miller L; Fastenau P; Bailey C; Chawa MS; Argenas A; Fiore M; Cooper KD; Lerner AJ
Biomed Res Int; 2022; 2022():8802469. PubMed ID: 35937394
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous T-cell lymphoma (CTCL) patients' understanding of illness and perception of follow-up.
Torosian A; Albucker SJ; Gowda G; Boh E; Bitar C
Int J Dermatol; 2023 Dec; 62(12):e645-e647. PubMed ID: 37548249
[No Abstract] [Full Text] [Related]
33. Erythrodermic CTCL: updated clues to diagnosis and treatment.
Bernengo MG; Quaglino P
G Ital Dermatol Venereol; 2012 Dec; 147(6):533-44. PubMed ID: 23149699
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
35. Maintenance therapy in cutaneous T-cell lymphoma: who, when, what?
Dummer R; Assaf C; Bagot M; Gniadecki R; Hauschild A; Knobler R; Ranki A; Stadler R; Whittaker S
Eur J Cancer; 2007 Nov; 43(16):2321-9. PubMed ID: 17707638
[TBL] [Abstract][Full Text] [Related]
36. [Cutaneous lymphomas. Quality Assurance Committee of the German Society of Dermatology and the Professional Organization of German Dermatologists e. V].
Dummer R
Hautarzt; 1998 Oct; 48 Suppl 1():S49-55. PubMed ID: 9866049
[No Abstract] [Full Text] [Related]
37. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.
Amber KT; Bloom R; Nouri K
Am J Clin Dermatol; 2016 Feb; 17(1):71-7. PubMed ID: 26386881
[TBL] [Abstract][Full Text] [Related]
38. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
[TBL] [Abstract][Full Text] [Related]
39. [Therapy of cutaneous T-cell lymphomas].
Rappersberger K; Ortel B; Forstinger C; Wolff K
Wien Klin Wochenschr; 1994; 106(10):300-8. PubMed ID: 8053197
[TBL] [Abstract][Full Text] [Related]
40. Primary cutaneous T-cell lymphoma occurring after organ transplantation.
Ravat FE; Spittle MF; Russell-Jones R
J Am Acad Dermatol; 2006 Apr; 54(4):668-75. PubMed ID: 16546591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
